HACKENSACK, N.J. and PETACH TIKVAH, Israel, June 14, 2017 /PRNewswire/ -- BrainStorm CellTherapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the Company will present a corporate overview at the BIO International Convention, taking place June
Date: Wednesday, June 21Time: 2:00pm Pacific TimePresenter: Chaim Lebovits, Chief Executive Officer, BrainStorm Cell TherapeuticsLocation: San Diego Convention Center, Company Presentation Theater 3Webcast: http://www.veracast.com/webcasts/bio/internationalconvention2017/96236165162.cfm
About BrainStorm Cell Therapeutics Inc. BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult mesenchymal stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwnŽ technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwnŽ has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel. In a randomized, double-blind, placebo-controlled clinical trial conducted in the U. S., a clinically meaningful benefit was demonstrated by higher response to NurOwn compared with placebo. For more information, visit the company's website at www.brainstorm-cell.com.
Media: Uri YablonkaBrainstorm Cell Therapeutics Inc.Phone: (646) email@example.com
Investors: Michael Rice LifeSci Advisors, LLCPhone: firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brainstorm-to-provide-corporate-update-at-the-bio-international-convention-300473770.html
SOURCE BrainStorm Cell Therapeutics Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All